Keros Therapeutics, Inc. - KROS

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$198.8M
QoQ value delta ($000)
-$10.35M (-4.95%)
Implied price effect (QoQ)
-3.18%
Shares
Total shares
18,579,556
QoQ shares delta
-345,368 (-1.82%)
Total shares held by funds (by quarter)

Market chart (KROS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 133 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
BlackRock, Inc. 29,898 2,794,217 0.0%
Nantahala Capital Management, LLC 15,091 1,410,419 0.5%
AQR CAPITAL MANAGEMENT LLC 10,356 967,859 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 8,919 833,596 0.0%
ORBIMED ADVISORS LLC 8,122 759,155 0.15%
FEDERATED HERMES, INC. 7,494 700,427 0.01%
VANGUARD PORTFOLIO MANAGEMENT LLC 6,983 652,635 0.0%
MACKENZIE FINANCIAL CORP 6,724 628,438 0.01%
Madison Avenue Partners, LP 6,704 626,583 0.29%
Qube Research & Technologies Ltd 6,514 608,837 0.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 6,478 605,445 0.02%
STATE STREET CORP 5,790 541,193 0.0%
GEODE CAPITAL MANAGEMENT, LLC 5,467 510,841 0.0%
DIMENSIONAL FUND ADVISORS LP 4,928 460,541 0.0%
CITADEL ADVISORS LLC 4,392 410,498 0.0%
RENAISSANCE TECHNOLOGIES LLC 3,842 359,086 0.01%
D. E. Shaw & Co., Inc. 2,861 267,460 0.0%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 2,835 265,017 0.05%
Nuveen, LLC 2,650 247,756 0.0%
ADAR1 Capital Management, LLC 2,640 246,818 0.12%
TWO SIGMA INVESTMENTS, LP 2,639 246,649 0.0%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 2,494 233,175 0.0%
MILLENNIUM MANAGEMENT LLC 1,977 184,822 0.0%
GOLDMAN SACHS GROUP INC 1,902 177,846 0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,698 158,712 0.0%